全文获取类型
收费全文 | 135632篇 |
免费 | 7787篇 |
国内免费 | 70篇 |
专业分类
林业 | 5576篇 |
农学 | 4644篇 |
基础科学 | 862篇 |
17483篇 | |
综合类 | 18956篇 |
农作物 | 5087篇 |
水产渔业 | 7089篇 |
畜牧兽医 | 72969篇 |
园艺 | 1798篇 |
植物保护 | 9025篇 |
出版年
2020年 | 1171篇 |
2019年 | 1410篇 |
2018年 | 2229篇 |
2017年 | 2489篇 |
2016年 | 2295篇 |
2015年 | 1999篇 |
2014年 | 2451篇 |
2013年 | 5731篇 |
2012年 | 4351篇 |
2011年 | 5163篇 |
2010年 | 3502篇 |
2009年 | 3547篇 |
2008年 | 5152篇 |
2007年 | 4970篇 |
2006年 | 4641篇 |
2005年 | 4262篇 |
2004年 | 4108篇 |
2003年 | 4174篇 |
2002年 | 3808篇 |
2001年 | 4773篇 |
2000年 | 4641篇 |
1999年 | 3747篇 |
1998年 | 1471篇 |
1997年 | 1452篇 |
1996年 | 1341篇 |
1995年 | 1599篇 |
1994年 | 1327篇 |
1993年 | 1359篇 |
1992年 | 2762篇 |
1991年 | 2901篇 |
1990年 | 2866篇 |
1989年 | 2897篇 |
1988年 | 2610篇 |
1987年 | 2592篇 |
1986年 | 2539篇 |
1985年 | 2400篇 |
1984年 | 1956篇 |
1983年 | 1715篇 |
1982年 | 1154篇 |
1979年 | 1649篇 |
1978年 | 1284篇 |
1977年 | 1135篇 |
1976年 | 1100篇 |
1975年 | 1164篇 |
1974年 | 1357篇 |
1973年 | 1448篇 |
1972年 | 1378篇 |
1971年 | 1195篇 |
1970年 | 1247篇 |
1969年 | 1146篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
994.
995.
996.
A. Lubojemska M. Borejko P. Czapiewski R. Dziadziuszko W. Biernat 《Veterinary and comparative oncology》2016,14(3):e70-e82
Olfactory neuroblastoma (ONB) is a rare tumour of nasal cavity and paranasal sinuses that arises from the olfactory neuroepithelium and has unpredictable clinical course. As the sense of smell is phylogenetically one of the first senses and olfactory neuroepithelium is evolutionary conserved with striking similarities among different species, we performed an extensive analysis of the literature in order to evaluate the similarities and differences between animals and humans on the clinical, morphological, immunohistochemical, ultrastructural and molecular level. Our analysis revealed that ONB was reported mainly in mammals and showed striking similarities to human ONB. These observations provide rationale for introduction of therapy modalities used in humans into the veterinary medicine. Animal models of neuroblastoma should be considered for the preclinical studies evaluating novel therapies for ONB. 相似文献
997.
998.
C. W. Locuson P. Williams J. M. Adcock J. S. Daniels 《Journal of veterinary pharmacology and therapeutics》2016,39(2):122-130
The dog CYP1A2 enzyme is likely an important contributor to the metabolism of veterinary drugs. Dog CYP1A2 is expressed in liver, plus it is inducible and polymorphic, creating the potential for intersubject differences in pharmacokinetics. Hence, the ability to probe dog CYP1A2 activity and inhibition is relevant toward veterinary drug development and drug–drug interaction assessment. Previous studies have relied on human probes with questionable specificity for CYP1A2, so it was hypothesized that recombinant CYP1A2 could be used to find a specific CYP1A2 substrate. Intrinsic clearance experiments demonstrated that tizanidine was a substrate of CYP1A2. Profiling of tizanidine metabolites generated by CYP1A2 identified the imidazole metabolite that was detectable in dog plasma. The imidazole metabolite was subsequently used to evaluate tizanidine as a CYP1A2 probe. Co‐administration of the CYP1A inhibitor enrofloxacin with tizanidine significantly decreased (30%; n = 3) the formation of the imidazole metabolite vs. control experiments. As enrofloxacin is a weak inhibitor, further studies are required to confirm the sensitivity of tizanidine as an in vivo probe. However, tizanidine may be a more selective CYP1A2 probe than phenacetin when conducting in vitro studies due to the presence of other phenacetin‐metabolizing enzymes in dog liver microsomes. 相似文献
999.
Pharmacokinetic indices for cefovecin after single‐dose administration to adult sea otters (Enhydra lutris) 下载免费PDF全文
E. A. Lee B. A. Byrne M. A. Young M. Murray M. A. Miller L. A. Tell 《Journal of veterinary pharmacology and therapeutics》2016,39(6):625-628
Seven sea otters received a single subcutaneous dose of cefovecin at 8 mg/kg body weight. Plasma samples were collected at predetermined time points and assayed for total cefovecin concentrations using ultra‐performance liquid chromatography and tandem mass spectrometry. The mean (±SD) noncompartmental pharmacokinetic indices were as follows: CMax (obs) 70.6 ± 14.6 μg/mL, TMax (obs) 2.9 ± 1.5 h, elimination rate constant (kel) 0.017 ± 0.002/h, elimination half‐life (t1/2kel) 41.6 ± 4.7 h, area under the plasma concentration‐vs.‐time curve to last sample (AUClast) 3438.7 ± 437.7 h·μg/mL and AUC extrapolated to infinity (AUC0→∞) 3447.8 ± 439.0 h·μg/mL. The minimum inhibitory concentrations (MIC) for select isolates were determined and used to suggest possible dosing intervals of 10 days, 5 days, and 2.5 days for gram‐positive, gram‐negative, and Vibrio parahaemolyticus bacterial species, respectively. This study found a single subcutaneous dose of cefovecin sodium in sea otters to be clinically safe and a viable option for long‐acting antimicrobial therapy. 相似文献
1000.